Standard of care (SoC) Group

BEHAVIORAL2 trials

Sponsors

Dr. Willmar Schwabe GmbH & Co. KG, Assistance Publique - Hôpitaux de Paris

Conditions

Impairment, CognitiveImpulse Control DisorderIschemic Stroke HospitalizedParkinson Disease

Phase 4

A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment

RecruitingNCT07220538

Dr. Willmar Schwabe GmbH & Co. KGImpairment, Cognitive, Ischemic Stroke Hospitalized

Start: 2025-11-28End: 2027-12-31Target: 400Updated: 2026-07-08

Unknown Phase

Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease

Not yet recruitingNCT07505394

Assistance Publique - Hôpitaux de ParisImpulse Control Disorder, Parkinson Disease

Start: 2026-07-01End: 2031-06-01Target: 528Updated: 2026-06-12